The CCT6A paradigm: biomarker potential and therapeutic challenges in oncology and beyond
This review delineates CCT6A’s multifunctional roles in oncogenesis and immune-metabolic dysregulation, critically evaluates its biomarker potential, and proposes targeted therapeutic frameworks to refine precision medicine paradigms across diverse disease landscapes.
Rui-Hang Du, Yi Cheng, Zi-Peng Ren et al.
· Molecular Biology Reports · 0 citations